ESPEN Congress 2026
Home
Full programme
Live Sessions
Speakers
Abstracts
E-posters
BASELINE TOTAL CHOLESTEROL (TCHOL) LEVELS AS SURROGATE MARKER OF MALNUTRITION IN PATIENTS (PTS) WITH ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) STARTING FIRST-LINE CHEMOTHERAPY
Sep 5, 2026
—
02:00 pm
-
12:00 PM
ePoster Area
ePoster display
PD718
BASELINE TOTAL CHOLESTEROL (TCHOL) LEVELS AS SURROGATE MARKER OF MALNUTRITION IN PATIENTS (PTS) WITH ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) STARTING FIRST-LINE CHEMOTHERAPY